ARCA biopharma - ABIO Competitors

Biomerica (NASDAQ:BMRA) and ARCA biopharma (NASDAQ:ABIO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, community ranking, risk, profitability, valuation and earnings.

Which has better valuation & earnings, BMRA or ABIO?

Biomerica has higher revenue and earnings than ARCA biopharma. Biomerica is trading at a lower price-to-earnings ratio than ARCA biopharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$18.87 million	1.76	-$4.53 million	-$0.43	-4.60
ARCA biopharma	N/A	N/A	-$9.93 million	-$0.69	-2.91

Does the media refer more to BMRA or ABIO?

In the previous week, ARCA biopharma had 3 more articles in the media than Biomerica. MarketBeat recorded 4 mentions for ARCA biopharma and 1 mentions for Biomerica. Biomerica's average media sentiment score of 1.11 beat ARCA biopharma's score of 0.58 indicating that Biomerica is being referred to more favorably in the media.

Company	Overall Sentiment
Biomerica	Positive
ARCA biopharma	Positive

Which has more risk and volatility, BMRA or ABIO?

Biomerica has a beta of -0.53, meaning that its share price is 153% less volatile than the S&P 500. Comparatively, ARCA biopharma has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500.

Is BMRA or ABIO more profitable?

ARCA biopharma has a net margin of 0.00% compared to Biomerica's net margin of -34.58%. ARCA biopharma's return on equity of -22.39% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-34.58%	-66.11%	-44.58%
ARCA biopharma	N/A	-22.39%	-21.21%

Does the MarketBeat Community favor BMRA or ABIO?

Biomerica received 14 more outperform votes than ARCA biopharma when rated by MarketBeat users. Likewise, 67.82% of users gave Biomerica an outperform vote while only 51.46% of users gave ARCA biopharma an outperform vote.

Company	Underperform	Outperform
Biomerica	Outperform Votes 137 67.82%	Underperform Votes 65 32.18%
ARCA biopharma	Outperform Votes 123 51.46%	Underperform Votes 116 48.54%

Do institutionals & insiders hold more shares of BMRA or ABIO?

22.0% of Biomerica shares are held by institutional investors. Comparatively, 15.4% of ARCA biopharma shares are held by institutional investors. 15.7% of Biomerica shares are held by insiders. Comparatively, 20.3% of ARCA biopharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Do analysts recommend BMRA or ABIO?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
ARCA biopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Biomerica and ARCA biopharma tied by winning 7 of the 14 factors compared between the two stocks.